Target
Mu-type opioid receptor
Ligand
BDBM464620
Substrate
n/a
Meas. Tech.
Receptor Binding Assay
Ki
175±n/a nM
Citation
 Kuehnert, SKoenigs, RMKless, AWegert, ARatcliffe, PJostock, RKoch, TLinz, KSchroeder, W 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives US Patent  US10793556 Publication Date 10/6/2020 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM464620
Synonyms:
CIS-3-(1-Benzoyl-piperidin-4-yl)-1-(cyclopropyl-methyl)-8-dimethylamino-8- phenyl-1,3-diazaspiro[4.5]decan-2-one | US10793556, Example SC_4049 | US10793556, Example SC_4050 | US10793556, Example SC_4051 | US10793556, Example SC_4052 | US10793556, Example SC_4053
Type:
Small organic molecule
Emp. Form.:
C31H41N5O2
Mol. Mass.:
515.6895
SMILES:
CN(C)[C@]1(CC[C@]2(CN(C3CCN(CC3)C(=O)c3ccncc3)C(=O)N2CC2CC2)CC1)c1ccccc1 |r,wU:6.27,3.2,(8.02,11.94,;6.53,12.33,;6.53,13.87,;5.44,11.25,;4.67,9.91,;3.13,9.91,;2.36,11.25,;1.46,12.49,;-.01,12.02,;-1.34,12.79,;-1.34,14.33,;-2.67,15.1,;-4.01,14.33,;-4.01,12.79,;-2.67,12.02,;-5.34,15.1,;-5.34,16.64,;-6.68,14.33,;-8.01,15.1,;-9.34,14.33,;-9.34,12.79,;-8.01,12.02,;-6.68,12.79,;-.01,10.48,;-1.25,9.57,;1.46,10,;1.93,8.53,;.9,7.39,;-.56,6.91,;.58,5.88,;3.13,12.58,;4.67,12.58,;6.78,10.48,;6.78,8.94,;8.11,8.17,;9.44,8.94,;9.44,10.48,;8.11,11.25,)|
Structure:
Search PDB for entries with ligand similarity: